#Zolgensma #Zolgensma #Zolgensma

Zolgensma Approved!

AveXis, a Novartis company, has received FDA approval for Zolgensma.

Learn MoreLearn More

Latest News

Cytokinetics Releases New Data from Reldesemtiv Clinical Study at the 2019 Annual SMA Conference

July 5, 2019

Cytokinetics Releases New Data from Reldesemtiv Clinical Study at the 2019 Annual SMA Conference

Cytokinetics, Incorporated,

READ MORE

Biogen Announces New NURTURE Data at the 2019 Annual SMA Conference

July 1, 2019

Biogen Announces New NURTURE Data at the 2019 Annual SMA Conference

Biogen

READ MORE

Updated SMA Drug Pipeline Now Available

June 28, 2019

Updated SMA Drug Pipeline Now Available

We’ve recently released an update to the SMA drug pipeline. This latest version includes:

What People Are Saying: 2019 North Jersey Walk-n-Roll

June 28, 2019

What People Are Saying: 2019 North Jersey Walk-n-Roll

The North Jersey Cure SMA Chapter held their 4th annual

READ MORE

The 2019 Annual SMA Conference is Here!

June 26, 2019

The 2019 Annual SMA Conference is Here!

The 2019 Annual SMA Conference, now in its 31st year, is set to kick off on June 28 and continue into a weekend full of

READ MORE

© 2019 Cure SMA | Cure SMA is recognized as tax-exempt under section 501(c)(3) of the Internal Revenue Code. EIN: 36-3320440. | Privacy Policy

Powered by Blackbaud
nonprofit software